Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia

被引：0
作者：
Scherbaum, W. A.
Schweizer, A.
Mari, A.
Nilsson, P. M.
Lalanne, G.
Jauffret, S.
Foley, J. E.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A134 / A134
页数：1
相关论文
共 50 条
[41]   T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients [J].
Thummasorn, Savitree ;
Apichai, Sopida ;
Chupradit, Supat ;
Sirisattayawong, Pornpen ;
Chaiwong, Pachpilai ;
Sriwichaiin, Sirawit ;
Pratchayasakul, Wasana ;
Chattipakorn, Nipon ;
Chattipakorn, Siriporn C. .
PLOS ONE, 2022, 17 (08)
[42]   EFFECT OF VILDAGLIPTIN ON ARTERIAL STIFFNESS IN DRUG NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS [J].
Zografou, I. ;
Sampanis, C. ;
Doukelis, P. ;
Anyfanti, P. ;
Nikolaidou, B. ;
Doumas, M. ;
Douma, S. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 :A140-A140
[43]   The Effect of Vildagliptin on Arterial Stiffness in Drug Naive Patients With Type 2 Diabetes Mellitus [J].
Zografou, Ioanna ;
Sampanis, Christos ;
Papageorgiou, Athanasios ;
Nikolaidou, Barbara ;
Doukelis, Panagiotis ;
Papadopoulou, Despina ;
Doumas, Michael ;
Douma, Stella .
DIABETES, 2013, 62 :A596-A596
[44]   Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis [J].
Kume, Shinji ;
Uzu, Takashi ;
Takagi, Chieko ;
Kondo, Morihiro ;
Okabe, Tomoko ;
Araki, Shin-ichi ;
Isshiki, Keiji ;
Takeda, Naoko ;
Kondo, Keiko ;
Haneda, Masakazu ;
Koya, Daisuke ;
Nishio, Yoshihiko ;
Kashiwagi, Atsunori ;
Maegawa, Hiroshi .
JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (03) :298-301
[45]   Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) [J].
Liu, Jie ;
Tarasenko, Lisa ;
Ellison, Misoo C. ;
Pong, Annpey ;
Huyck, Susan ;
Mancuso, James P. ;
Terra, Steven G. ;
Gantz, Ira .
DIABETES, 2019, 68
[46]   Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM) [J].
Liu, Jie ;
Tarasenko, Lisa ;
Pong, Annpey ;
Huyck, Susan ;
Wu, Larry ;
Mancuso, James P. ;
Terra, Steven ;
Lauring, Brett .
DIABETES, 2018, 67
[47]   Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Concomitant Heart Failure [J].
Kosiborod, Mikhail ;
Gause-Nilsson, Ingrid Ami ;
Sonesson, Christian ;
Sugg, Jennifer E. ;
Johnsson, Eva .
DIABETES, 2015, 64 :A313-A313
[48]   Prolonged hyperglycemia uncovers β-cell weakness in first degree relatives (FDR) of patients with type 2 diabetes (T2DM) [J].
Boden, G ;
Chen, XH ;
Mozzoli, M .
DIABETES, 1999, 48 :A69-A69
[49]   Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM) [J].
Weinzimer, SA ;
McKnight, WJ ;
Murphy, K ;
Jawad, AF ;
Celona-Jacobs, N ;
Haque, A ;
Katz, LEL .
DIABETES, 2001, 50 :A68-A68
[50]   The efficacy and tolerability of topiramate controlled-release in the treatment of obese type 2 diabetes (T2DM) managed with diet or metformin [J].
Rosenstock, J ;
Hollander, P ;
Gadde, KM ;
Leung, AT ;
Sun, X ;
Strauss, R .
DIABETES, 2005, 54 :A12-A12
12345